Bio

Benjamin Hsu is a Managing Director of Cornell Capital. Prior to joining the firm in 2020, Benjamin served as Chief Strategy Officer and Head of Global Business Development of Sundia MediTech, a venture-backed pre-clinical CRO, where he was responsible for corporate strategy, business development, M&A and financing activities, investor relations and also acted as board secretary. He began his career at Goldman Sachs in the Investment Banking Division in the Corporate Finance Group in Hong Kong.